RefBan

Referral Banners

Thursday, April 11, 2013

Daily Investor Briefing: Wall Street rises for fourth day, but...

Click to View in Browser
04/11/2013
Reuters Election 2012 Daily round-up of the day's top news from the campaign trail, the White House and all the politics in between
Wall Street rises for fourth day, but weak tech hits Nasdaq
NEW YORK (Reuters) - Stocks rose for a fourth straight day on Thursday, sending the Dow and the S&P 500 to new closing highs as positive data on the labor market and an encouraging retail outlook eased recent concerns about economic growth.
Obama talks about economy, immigration in meeting with bankers
WASHINGTON (Reuters) - President Barack Obama stressed the need to revive the economy and reform immigration and fiscal policy during a meeting on Thursday with some of the world's most powerful bankers.
Martha Stewart loses bid to dismiss Macy's contract claim
NEW YORK (Reuters) - Martha Stewart's company lost a bid on Thursday to dismiss Macy's Inc's claim that it violated their contract when it designed certain products for J.C. Penney Co Inc, even if the products do not carry the Martha Stewart brand.
U.S. charges ex-KPMG auditor in tips-for-cash scheme
NEW YORK (Reuters) - Authorities on Thursday filed criminal and civil charges against a former KPMG senior auditor who is accused of passing non-public information about five of KPMG's corporate clients to a golfing buddy who traded on the tips.
BlackBerry tumbles as analysts rekindle turnaround doubts
TORONTO (Reuters) - Shares of BlackBerry slipped about 8 percent on Thursday as analysts questioned whether the handset maker's turnaround plan would succeed in the brutally competitive smartphone market.
States moved beyond budget crises in 2012: Census
WASHINGTON (Reuters) - The worst of the budget crunch that afflicted state governments after the 2008 financial crisis appears over, data from the Census showed on Thursday.
Exclusive: Royalty Pharma considers sweetened deal for Elan - sources
NEW YORK (Reuters) - Investment firm Royalty Pharma is considering sweetening its $6.6 billion offer for Irish drugmaker Elan by paying Elan shareholders more if the multiple sclerosis drug Tysabri hits certain sales milestones, two people familiar with the matter said on Thursday.
SEC tells banks to improve structured note disclosures: filings
NEW YORK (Reuters) - The Securities and Exchange Commission told five big Wall Street banks last year to improve disclosures about structured notes that are mostly sold to retail investors, and criticized use of the term "principal protected" in marketing materials.
Japan carmakers recall 3.4 million vehicles for Takata airbag flaw
TOKYO/DETROIT (Reuters) - Four Japanese automakers, including Toyota Motor Corp and Nissan Motor Co, are recalling 3.4 million vehicles sold around the world because airbags supplied by Takata Corp are at risk of catching fire or injuring passengers.
Exclusive: Apax, Morgan Stanley look to sell Hub - sources
NEW YORK (Reuters) - Buyout firm Apax Partners and Morgan Stanley's private equity arm are exploring a sale of Chicago-based insurance brokerage Hub International that could be valued at around $2 billion, two people familiar with the matter said this week.
Related Video
Pent-up demand should help April retail sales-ICSC's Niemira
Techquity: Apple software in spotlight, PC shipments weak
Related News

The sorrow and the pity of Obama's budget

Owe taxes and can't pay? You have options
SUBSCRIBE TO OTHER REUTERS NEWSLETTERS
Before the Bell
A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today  
 Reuters Deals Today
The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today  
» MORE NEWSLETTERS
- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters
Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details
Subscribe to other Reuters newsletters.
Unsubscribe from this newsletter.
Follow us on Twitter facebook Friend us on Facebook Forward this newsletter to a friend Forward to a friend

No comments: